Literature DB >> 15891965

The use of growth factors on tendon injuries.

Vishal Mehta1, Daniel Mass.   

Abstract

Tendon injuries continue to be a vexing clinical problem faced by the upper extremity surgeon. These injuries often lead to disability and dissatisfaction for both the patient and treating physician. Advances throughout the century have focused largely on improvements in surgical techniques and therapy protocols. Recently, attention has been turned to the biologic pathways by which tendons heal and the growth factors involved in this process have been identified. There is great hope that these growth factors may one day be used to treat tendon injuries. This article provides a summary of the use of growth factors on tendon injuries including contemporary research, delivery methods, and future directions in this field.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891965     DOI: 10.1197/j.jht.2005.01.012

Source DB:  PubMed          Journal:  J Hand Ther        ISSN: 0894-1130            Impact factor:   1.950


  3 in total

1.  Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers.

Authors:  Andrew Park; Macalus V Hogan; Girish S Kesturu; Roshan James; Gary Balian; Abhinav Bobby Chhabra
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

2.  Insulin immobilized PCL-cellulose acetate micro-nanostructured fibrous scaffolds for tendon tissue engineering.

Authors:  Daisy M Ramos; Sama Abdulmalik; Michael R Arul; Swetha Rudraiah; Cato T Laurencin; Augustus D Mazzocca; Sangamesh G Kumbar
Journal:  Polym Adv Technol       Date:  2019-02-04       Impact factor: 3.665

3.  Injured Achilles Tendons Treated with Adipose-Derived Stem Cells Transplantation and GDF-5.

Authors:  Andrea Aparecida de Aro; Giane Daniela Carneiro; Luis Felipe R Teodoro; Fernanda Cristina da Veiga; Danilo Lopes Ferrucci; Gustavo Ferreira Simões; Priscyla Waleska Simões; Lúcia Elvira Alvares; Alexandre Leite R de Oliveira; Cristina Pontes Vicente; Caio Perez Gomes; João Bosco Pesquero; Marcelo Augusto M Esquisatto; Benedicto de Campos Vidal; Edson Rosa Pimentel
Journal:  Cells       Date:  2018-08-31       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.